Skip to main content
. Author manuscript; available in PMC: 2015 Mar 31.
Published in final edited form as: Gynecol Oncol. 2009 Jul 12;115(1):81–85. doi: 10.1016/j.ygyno.2009.06.021

Table 1.

Number of patients with CA-125 data for intravenous and intraperitoneal chemotherapy.

Cycle Intravenous chemotherapy
Intraperitoneal chemotherapy
Expected Observed Missing (%) Expected Observed Missing (%)
Pre-1st 208 177 31 (15) 189 165 24 (13)
Pre-2nd 200 149 51 (26) 149 122 27 (18)
Pre-3rd 191 150 41 (22) 119 91 28 (24)
Pre-4th 180 138 42 (23) 104 88 16 (15)
Pre-5th 178 144 34 (19) 97 80 17 (18)
Pre-6th 173 129 44 (25) 86 79 7 (8)